Breast Cancer is the most common cancer among women. Each year more than 4000 women in Denmark are diagnosed with breast cancer - and this number has increased steadily during the past 40 years. In Norway, Sweden and Finland the corresponding numbers are: 3000, 6000 and 4000.
Eventhough treatments have improved, it is still a fact that 40% of women diagnosed with breast cancer die within 10 years of diagnosis. This number is approx. 10% lower in Sweden, Finland and Norway.
We need to be innovative and old traditions need to be put aside. We need to work across paradigms, organisations, disciplines and boundaries - and this is eactly what has formed the basis and is the core of the research within The Danish Center for Translational Breast Cancer Research.
Facts about Breast Cancer
DTCB´s mål
- To identify markers and "molecular signatures", i.e. specific characteristics which can be used to classify each individual tumor and thereby each individual patient - such a classification is a prerequisite for tailormade and more effective treatment forms.
- To identify markers and signatures which can lead the way to earlier detection, a more accurate prognosis and improved ability to predict the effects of the treatment of each individual patient.